Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Dayyani

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|October 17, 2025
Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric CancerArsha Ostowari, Kathryn T Chen, Bima J Hasjim, et al.
The Oncologist|June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
Journal of Surgical Oncology|September 9, 2020
Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk?Audrey H Choi, Liang Ji, Blake Babcock, et al.
Blood|February 27, 2008
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemiasWoo Jae Kim, Ross A Okimoto, Louise E Purton, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
JNCI Cancer Spectrum|December 16, 2022
Expanding access to early phase trials: the CATCH-UP.2020 experienceJoaquina C Baranda, Francisco J Diaz, Larry Rubinstein, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
Journal of Hepatology|July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE studyDo-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Cancer Cell|October 13, 2023
Progenitor-like exhausted SPRY1<sup>+</sup>CD8<sup>+</sup> T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinomaZhichao Liu, Yaru Zhang, Ning Ma, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|October 17, 2025
Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric CancerArsha Ostowari, Kathryn T Chen, Bima J Hasjim, et al.
The Oncologist|June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
Journal of Surgical Oncology|September 9, 2020
Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk?Audrey H Choi, Liang Ji, Blake Babcock, et al.
Blood|February 27, 2008
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemiasWoo Jae Kim, Ross A Okimoto, Louise E Purton, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
JNCI Cancer Spectrum|December 16, 2022
Expanding access to early phase trials: the CATCH-UP.2020 experienceJoaquina C Baranda, Francisco J Diaz, Larry Rubinstein, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
Journal of Hepatology|July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE studyDo-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Cancer Cell|October 13, 2023
Progenitor-like exhausted SPRY1<sup>+</sup>CD8<sup>+</sup> T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinomaZhichao Liu, Yaru Zhang, Ning Ma, et al.
Pageof 12